Page last updated: 2024-09-05

l 659066 and Canine Diseases

l 659066 has been researched along with Canine Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Honkavaara, J; Huuskonen, V; Pesonen, T; Raekallio, M; Restitutti, F; Vainio, O1
Honkavaara, JM; Hyvärinen, EA; Kuusela, EK; Raekallio, MR; Vainio, OM1

Trials

2 trial(s) available for l 659066 and Canine Diseases

ArticleYear
Cardiovascular effects of dobutamine, norepinephrine and phenylephrine in isoflurane-anaesthetized dogs administered dexmedetomidine-vatinoxan.
    Veterinary anaesthesia and analgesia, 2022, Volume: 49, Issue:6

    Topics: Anesthetics, Inhalation; Animals; Blood Pressure; Dexmedetomidine; Dobutamine; Dog Diseases; Dogs; Hypotension; Isoflurane; Norepinephrine; Phenylephrine; Saline Solution

2022
The effects of L-659,066, a peripheral alpha2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs.
    Veterinary anaesthesia and analgesia, 2008, Volume: 35, Issue:5

    Topics: Adrenergic Antagonists; Anesthesia; Animals; Bradycardia; Cross-Over Studies; Dexmedetomidine; Dog Diseases; Dogs; Hypnotics and Sedatives; Quinolizines

2008